Neurobiological Basis of Increased Risk for Suicidal Behaviour
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
According to the World Health Organization (WHO), more than 700,000 people die per year due to suicide. Suicide risk factors include a previous suicide attempt and psychiatric disorders. The highest mortality rate in suicide worldwide is due to depression. Current evidence suggests that suicide etiopathogenesis is associated with neuroinflammation that activates the kynurenine pathway and causes subsequent serotonin depletion and stimulation of glutamate neurotransmission. These changes are accompanied by decreased BDNF (brain-derived neurotrophic factor) levels in the brain, which is often linked to impaired neuroplasticity and cognitive deficits. Most suicidal patients have a hyperactive hypothalamus–pituitary–adrenal (HPA) axis. Epigenetic mechanisms control the above-mentioned neurobiological changes associated with suicidal behaviour. Suicide risk could be attenuated by appropriate psychological treatment, electroconvulsive treatment, and drugs: lithium, ketamine, esketamine, clozapine. In this review, we present the etiopathogenesis of suicide behaviour and explore the mechanisms of action of anti-suicidal treatments, pinpointing similarities among them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115 · cited 1×
“Other risk factors are schizophrenia, post-traumatic stress disorder (PTSD), anorexia nervosa, sleep disorder, antisocial personality disorder, borderline personality disorder, and/or substance abuse [3,7,11,12].”
BackgroundExtrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 1×
“In the CSF of suicide attempters and patients with suicidal intent, increased levels of QUIN were observed, regardless of mood disorder comorbidity [31,61].”
BackgroundEpidemiology of suicide and the psychiatric perspective
Bachmann, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15071425 · Cited by 1,377 · cited 2×
“Completed suicides are three times more common in males than females, while for suicide attempts, an inverse ratio is observed [2].”
BackgroundNeurobiology of suicidal behaviour
Mann, J. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1220 · Cited by 1,260 · cited 9×
“The CSF’s lower levels of the major serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) were found in suicide attempters with psychiatric disorders as compared with psychiatric non-attempters and healthy controls [3,35,65,66].”
BackgroundInfluentialSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Cognitive Therapy for the Prevention of Suicide Attempts: A Randomized Controlled Trial
Brown, G. K., Ten Have, T., Henriques, G. R., Xie, S. X., Hollander, J. E., & Beck, A. T. (2005) · JAMA · doi:10.1001/jama.294.5.563 · Cited by 1,045
Muldoon, M. F., Manuck, S. B., & Matthews, K. A. (1990) · BMJ · doi:10.1136/bmj.301.6747.309 · Cited by 960 · cited 1×
“Interest in cholesterol as a biomarker for suicide has been growing since the early 1990s, when a meta-analysis of randomised primary prevention trials of statins (cholesterol-lowering drugs) indicated that they reduced the risk of death by coronary events but increased the risk of suicide [96,97].”
BackgroundLithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920
Meta-analysis of sleep disturbance and suicidal thoughts and behaviors
Pigeon, W. R., Pinquart, M., & Conner, K. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07586 · Cited by 815
Zarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811
Decreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Epigenetics in health and disease
Zhang, L., Lu, Q., & Chang, C. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3449-2_1 · Cited by 689 · cited 1×
“They include DNA methylation, histone modification (methylation or acethylation), and microRNA (miRNA) [100].”
BackgroundFazel, S., & Runeson, B. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1902944 · Cited by 502
Suicidal behaviour: an epidemiological and genetic study
STATHAM, D. J., HEATH, A. C., MADDEN, P. A. F., BUCHOLZ, K. K., BIERUT, L., DINWIDDIE, S. H., SLUTSKE, W. S., DUNNE, M. P., & MARTIN, N. G. (1998) · Psychological Medicine · doi:10.1017/s0033291798006916 · Cited by 471 · cited 2×
“Suicidal behaviour is thought to be triggered by an interplay between genetic, psychological, and environmental factors [19].”
BackgroundSequeira, A., Mamdani, F., Ernst, C., Vawter, M. P., Bunney, W. E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006585 · Cited by 388 · cited 1×
“Suicide victims are characterised by an increased expression of GABA-A receptors in the hippocampus and prefrontal cortex [86,87].”
BackgroundImaging suicidal thoughts and behaviors: a comprehensive review of 2 decades of neuroimaging studies
Schmaal, L., van Harmelen, A.-L., Chatzi, V., Lippard, E. T. C., Toenders, Y. J., Averill, L. A., Mazure, C. M., & Blumberg, H. P. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0587-x · Cited by 373 · cited 3×
“Structural MRI studies have shown lower grey matter volume and neural density in the ventral PFC and reduced hippocampal volumes in adults who had attempted suicide than in psychiatric controls [8,30].”
BackgroundArango, V (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00310-4 · Cited by 368
Connecting inflammation with glutamate agonism in suicidality
Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.248 · Cited by 345 · cited 20×
“The increase of QUIN in CSF patients who have recently attempted suicide was very potent, i.e., about 300% [31].”
BackgroundMethodInfluentialPoulter, M. O., Du, L., Weaver, I. C. G., Palkovits, M., Faludi, G., Merali, Z., Szyf, M., & Anisman, H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.028 · Cited by 331
Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., & Dwivedi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033201 · Cited by 324
The Neurobiological Basis of Suicide
(2012) · doi:10.1201/b12215 · Cited by 301
Toward a Biosignature for Suicide
Oquendo, M. A., Sullivan, G. M., Sudol, K., Baca-Garcia, E., Stanley, B. H., Sublette, M. E., & Mann, J. J. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020194 · Cited by 299 · cited 4×
“Subsequently, most studies have reported decreases or no difference in NMDA binding in the prefrontal cortex in cases of suicide [70,84,85].”
BackgroundInfluentialKlempan, T. A., Sequeira, A., Canetti, L., Lalovic, A., Ernst, C., ffrench-Mullen, J., & Turecki, G. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002110 · Cited by 294
Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., Brutsché, N. E., Ameli, R., Furey, M. L., & Zarate, C. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.027 · Cited by 286
Treatment-resistant depression and suicidality
Bergfeld, I. O., Mantione, M., Figee, M., Schuurman, P. R., Lok, A., & Denys, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.016 · Cited by 256 · cited 1×
“On the one hand, thirty percent of patients with treatment-resistant depression attempt suicide at least once during their life [9].”
BackgroundPlasma kynurenine levels are elevated in suicide attempters with major depressive disorder
Sublette, M. E., Galfalvy, H. C., Fuchs, D., Lapidus, M., Grunebaum, M. F., Oquendo, M. A., John Mann, J., & Postolache, T. T. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.05.002 · Cited by 250 · cited 1×
“Patients with suicide attempts and depression have higher kynurenine levels than patients with depression without suicide attempts [1,31,62].”
BackgroundVermeulen, J. M., van Rooijen, G., van de Kerkhof, M. P. J., Sutterland, A. L., Correll, C. U., & de Haan, L. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby052 · Cited by 246
The role of cytokines in the pathophysiology of suicidal behavior
Ganança, L., Oquendo, M. A., Tyrka, A. R., Cisneros-Trujillo, S., Mann, J. J., & Sublette, M. E. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.008 · Cited by 217
A literature review and meta-analyses of cannabis use and suicidality
Borges, G., Bagge, C. L., & Orozco, R. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.007 · Cited by 214
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Malik, S., Kanwar, A., Sim, L. A., Prokop, L. J., Wang, Z., Benkhadra, K., & Murad, M. H. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-18 · Cited by 206
Brundin, L., Sellgren, C. M., Lim, C. K., Grit, J., Pålsson, E., Landén, M., Samuelsson, M., Lundgren, K., Brundin, P., Fuchs, D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.133 · Cited by 195
Discovery and validation of blood biomarkers for suicidality
Le-Niculescu, H., Levey, D. F., Ayalew, M., Palmer, L., Gavrin, L. M., Jain, N., Winiger, E., Bhosrekar, S., Shankar, G., Radel, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.95 · Cited by 193 · cited 3×
“SAT1 is highly inducible by stress and cytokines [40].”
BackgroundInfluentialSerafini, G., Parisi, V. M., Aguglia, A., Amerio, A., Sampogna, G., Fiorillo, A., Pompili, M., & Amore, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072393 · Cited by 172
Kynurenine pathway metabolites and suicidality
Bryleva, E. Y., & Brundin, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.034 · Cited by 168
Serotonergic genes and suicide: A systematic review
Antypa, N., Serretti, A., & Rujescu, D. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.013 · Cited by 150
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Gould, T. D., Zarate, C. A., & Thompson, S. M. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052811 · Cited by 133
Genetic associations with suicide attempt severity and genetic overlap with major depression
Levey, D. F., Polimanti, R., Cheng, Z., Zhou, H., Nuñez, Y. Z., Jain, S., He, F., Sun, X., Ursano, R. J., Kessler, R. C., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0340-2 · Cited by 124 · cited 1×
“Genome-wide association studies (GWAS) have indicated that polygenic risk and specific loci such as genes involved in circadian clock regulation, tyrosine metabolism, and risk factors for depressive disorder are associated with a higher risk of attempting suicide [20,21].”
BackgroundFragoso, Y. D., Frota, E. R. C., Lopes, J. S., Noal, J. S., Giacomo, M. C., Gomes, S., Gonçalves, M. V. M., da Gama, P. D., & Finkelsztejn, A. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181f8d513 · Cited by 116 · cited 2×
“An elevated level of TNF-α was noticed in the dorsolateral prefrontal cortex of individuals who died by suicide, regardless of psychiatric diagnosis [23]; this observation supports the fact that interferon treatment increases the risk of depression and suicide [50,51].”
BackgroundResultAssociations of Suicidality Trends With Cannabis Use as a Function of Sex and Depression Status
Han, B., Compton, W. M., Einstein, E. B., & Volkow, N. D. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.13025 · Cited by 106
Verdonk, F., Petit, A.-C., Abdel-Ahad, P., Vinckier, F., Jouvion, G., de Maricourt, P., De Medeiros, G. F., Danckaert, A., Van Steenwinckel, J., Blatzer, M., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.033 · Cited by 99
An inflammatory profile linked to increased suicide risk
Keaton, S. A., Madaj, Z. B., Heilman, P., Smart, L., Grit, J., Gibbons, R., Postolache, T. T., Roaten, K., Achtyes, E. D., & Brundin, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.100 · Cited by 95
Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits
Beurel, E., & Jope, R. S. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.129 · Cited by 92
Yin, H., Pantazatos, S. P., Galfalvy, H., Huang, Y., Rosoklija, G. B., Dwork, A. J., Burke, A., Arango, V., Oquendo, M. A., & Mann, J. J. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32423 · Cited by 91 · cited 1×
“In addition, a pilot study examining the GABAergic system in suicide found decreased GABA-A gamma subunit expression in the prefrontal cortex of patients with depressive disorder and schizophrenia [88].”
BackgroundBiological bases of suicidal behaviours: a narrative review
Lengvenyte, A., Conejero, I., Courtet, P., & Olié, E. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14635 · Cited by 87
Murphy, T. M., Mullins, N., Ryan, M., Foster, T., Kelly, C., McClelland, R., O'Grady, J., Corcoran, E., Brady, J., Reilly, M., et al. (2013) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00865.x · Cited by 74
Suicide in Northern Ireland: epidemiology, risk factors, and prevention
O'Neill, S., & O'Connor, R. C. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30525-5 · Cited by 67 · cited 1×
“A chronic and acute stressful situation such as deprivation, isolation, family adversity, sexual abuse, school, employment and financial difficulties, and experiences of loss and death can increase the incidence of suicidal behaviour [27,28].”
BackgroundJokinen, J., Boström, A. E., Dadfar, A., Ciuculete, D. M., Chatzittofis, A., Åsberg, M., & Schiöth, H. B. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.018 · Cited by 67 · cited 3×
“Depressed suicide patients had increased corticotrophin-releasing hormone (CRH) levels in the paraventricular nucleus of the hypothalamus, forebrain, locus coeruleus, and fewer CRH1 receptors in the frontopolar cortex [70,81,82] (Jokinen et al.”
BackgroundAssociation between BDNF levels and suicidal behaviour: a systematic review and meta-analysis
Eisen, R. B., Perera, S., Banfield, L., Anglin, R., Minuzzi, L., & Samaan, Z. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0179-z · Cited by 51 · cited 3×
“Moreover, downregulation of BDNF in the anterior cingulate cortex and amygdala, and lower serum BDNF levels, have been reported in depressed patients with suicidal intentions as compared with depressed patients without suicidal intentions [30,73,75].”
BackgroundResultNeurobiological aspects of suicide and suicide attempts in bipolar disorder
Mathews, D., Richards, E., Niciu, M., Ionescu, D., Rasimas, J., & Zarate, C. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0120-7 · Cited by 39 · cited 3×
“Higher methylation levels of the BDNF, GABA-A receptor subunits, and TrkB receptor promoters, as well as the NR3C1 gene (coding glucocorticoid receptor promoter), have been observed in suicide victims than in controls [67,74,101].”
BackgroundHopkins, A. G., Spiller, H. A., Kistamgari, S., Zhu, M., Michaels, N. L., Funk, A. R., & Smith, G. A. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4997 · Cited by 35
Research works printed but not linked: 109
- Milner, 2012, Suicide in the absence of mental disorder? A review of psychological autopsy studies across countries, Int. J. Soc. Psychiatry, 59, 545, 10.1177/0020764012444259 · DOI · Paper page
- Roy, 2017, Understanding epigenetic architecture of suicide neurobiology: A critical perspective, Neurosci. Biobehav. Rev., 72, 10, 10.1016/j.neubiorev.2016.10.031 · DOI · Paper page
- De Berardis, D., Fornaro, M., Valchera, A., Cavuto, M., Perna, G., Di Nicola, M., Serafini, G., Carano, A., Pompili, M., and Vellante, F. (2018). Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors. Int. J. Mol. Sci., 19. · DOI · Paper page
- Baldessarini, 2019, Epidemiology of suicide: Recent developments, Epidemiol. Psychiatr. Sci., 29, e71, 10.1017/S2045796019000672 · DOI · Paper page
- Borges, 2017, A meta-analysis of acute use of alcohol and the risk of suicide attempt, Psychol. Med., 47, 949, 10.1017/S0033291716002841 · DOI · Paper page
- Meltzer, 2003, Serotonin receptors their key role in drugs to treat schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 1159, 10.1016/j.pnpbp.2003.09.010 · DOI · Paper page
- Mortensen, 2000, Psychiatric illness and risk factors for suicide in Denmark, Lancet, 355, 9, 10.1016/S0140-6736(99)06376-X · DOI · Paper page
- Breslau, 1992, Migraine, suicidal ideation, and suicide attempts, Neurology, 42, 392, 10.1212/WNL.42.2.392 · DOI · Paper page
- McFarland, 2019, Suicide in patients with cancer: Identifying the risk factors, Oncology, 33, 221
- Calati, 2020, Candidate biomarkers of suicide crisis syndrome: What to test next? A concept paper, Int. J. Neuropsychopharmacol., 23, 192, 10.1093/ijnp/pyz063 · DOI
- Martinez, 2020, Glutamine and new pharmacological targets to treat suicidal ideation, Curr. Top. Behav. Neurosci., 46, 179, 10.1007/7854_2020_168 · DOI
- Perroud, 2011, Impulsivity, aggression and suicidal behavior in unipolar and bipolar disorders, J. Affect. Disord., 134, 112, 10.1016/j.jad.2011.05.048 · DOI
- Mullins, 2019, GWAS of suicide attempt in psychiatric disorders and association with major depression polygenic risk scores, Am. J. Psychiatry., 176, 651, 10.1176/appi.ajp.2019.18080957 · DOI · Paper page
- Chu, 2017, The role of stressful life events preceding death by suicide: Evidence from two samples of suicide decedents, Psychiatry Res., 256, 345, 10.1016/j.psychres.2017.06.078 · DOI
- Dwivedi, 2018, MicroRNAs in depression and suicide: Recent insights and future perspectives, J. Affect. Disord., 240, 146, 10.1016/j.jad.2018.07.075 · DOI · Paper page
- Lenz, 2019, The androgen model of suicide completion, Prog. Neurobiol., 172, 84, 10.1016/j.pneurobio.2018.06.003 · DOI
- Killgore, 2020, Trends in suicidal ideation over the first three months of COVID-19 lockdowns, Psychiatry Res., 293, 113390, 10.1016/j.psychres.2020.113390 · DOI · Paper page
- Allen, 2020, MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior, Mol. Psychiatry, 25, 308, 10.1038/s41380-019-0597-8 · DOI
- Orsolini, 2020, Understanding the complex of suicide in depression: From research to clinics, Psychiatry Investig., 17, 207, 10.30773/pi.2019.0171 · DOI · Paper page
- Sueki, 2020, Relationship between beck hopelessness scale and suicidal ideation: A short-term longitudinal study, Death Stud., 17, 1
- Asarnow, 2012, Suicide attempt risk in youths: Utility of the harkavy-asnis suicide scale for monitoring risk levels, Suicide Life-Threat. Behav., 42, 684, 10.1111/j.1943-278X.2012.00122.x · DOI
- Ofek, 1998, The child suicide potential scale: Inter-rater reliability and validity in Israeli in-patient adolescents, Isr. J. Psychiatry Relat. Sci., 35, 253
- Miura, 2008, A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression, Stress, 11, 198, 10.1080/10253890701754068 · DOI · Paper page
- Pandey, 2013, Biological basis of suicide and suicidal behavior, Bipolar Disord., 15, 524, 10.1111/bdi.12089 · DOI · Paper page
- Niculescu, 2015, Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach, Mol. Psychiatry, 20, 1266, 10.1038/mp.2015.112 · DOI · Paper page
- Niculescu, 2017, Precision medicine for suicidality: From universality to subtypes and personalisation, Mol. Psychiatry., 22, 1250, 10.1038/mp.2017.128 · DOI · Paper page
- Lin, H.-T., Lai, C.-H., Perng, H.-J., Chung, C.-H., Wang, C.-C., Chen, W.-L., and Chien, W.-C. (2018). Insomnia as an independent predictor of suicide attempts: A nationwide population-based retrospective cohort study. BMC Psychiatry, 18. · DOI
- Amitai, 2020, Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth, Brain Behav. Immun., 87, 301, 10.1016/j.bbi.2019.12.017 · DOI
- Cha, 2017, Annual research review: Suicide among youth—epidemiology, (potential) etiology, and treatment, J. Child Psychol. Psychiatry, 59, 460, 10.1111/jcpp.12831 · DOI · Paper page
- Sudol, 2017, Biomarkers of sicide attempt behavior: Towards biological model of risk, Curr. Psychiatry. Rep., 19, 31, 10.1007/s11920-017-0781-y · DOI · Paper page
- Sockalingam, 2010, Suicide risk in hepatitis C and during interferon-alpha therapy: A review and clinical update, J. Viral Hepat., 18, 153, 10.1111/j.1365-2893.2010.01393.x · DOI · Paper page
- Stuart, 2014, Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies, Neurosci. Biobehav. Rev., 42, 93, 10.1016/j.neubiorev.2014.02.001 · DOI · Paper page
- Nassar, 2014, Effects of lithium on inflammation, ACS Chem. Neurosci., 5, 451, 10.1021/cn500038f · DOI · Paper page
- Lehrer, 2019, Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce suicidal ideation and depression, Discov. Med, 28, 205
- Lydholm, 2019, Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: Meta-analysis of clinical trials, Acta Psychiatr. Scand., 139, 404, 10.1111/acps.13016 · DOI · Paper page
- Fourrier, 2018, Anti-inflammatory treatment of depression: Study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo, Trials, 19, 447, 10.1186/s13063-018-2829-7 · DOI · Paper page
- Halaris, 2020, Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial, J. Affect. Disord., 261, 145, 10.1016/j.jad.2019.10.021 · DOI · Paper page
- Sas, K., Szabó, E., and Vécsei, L. (2018). Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection. Molecules, 23. · DOI · Paper page
- Schwieler, 2018, Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia, Neuropharmacology, 138, 130, 10.1016/j.neuropharm.2018.06.003 · DOI
- Savitz, 2020, The kynurenine pathway: A finger in every pie, Mol. Psychiatry, 25, 131, 10.1038/s41380-019-0414-4 · DOI · Paper page
- Asberg, 1976, 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?, Arch. Gen. Psychiatry., 33, 1193, 10.1001/archpsyc.1976.01770100055005 · DOI · Paper page
- Sher, 2006, A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder, Bipolar Disord., 8, 543, 10.1111/j.1399-5618.2006.00319.x · DOI
- Pandey, 2013, Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims, Psychoneuroendocrinology, 38, 2628, 10.1016/j.psyneuen.2013.06.020 · DOI
- Stockmeier, 1997, Serotonin receptors in suicide victims with major depression, Neuropsychopharmacology, 16, 162, 10.1016/S0893-133X(96)00170-4 · DOI
- Bennett, 2000, Tryptophan hydroxylase polymorphisms in suicide victims, Psychiatr. Genet., 10, 13, 10.1097/00041444-200010010-00003 · DOI
- Autry, 2009, Epigenetics in suicide and depression, Biol. Psychiatry, 66, 812, 10.1016/j.biopsych.2009.08.033 · DOI · Paper page
- Misztak, P., Pańczyszyn-Trzewik, P., Nowak, G., and Sowa-Kućma, M. (2020). Epigenetic marks and their relationship with BDNF in the brain of suicide victims. PLoS ONE, 15. · DOI
- 2017, Decrease in brain-derived neurotrophic factor at plasma level but not in serum concentrations in suicide behavior: A systematic review and meta-analysis, Brain Behav., 7, e00706, 10.1002/brb3.706 · DOI · Paper page
- Pompili, 2010, The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: A selective overview for the implications of suicide prevention, Eur. Arch. Psychiatry Clin. Neurosci., 260, 583, 10.1007/s00406-010-0108-z · DOI · Paper page
- Yerevanian, 2004, Antidepressants and suicidal behaviour in unipolar depression, Acta Psychiatr. Scand., 110, 452, 10.1111/j.1600-0447.2004.00437.x · DOI · Paper page
- Turecki, 2014, Epigenetics and suicidal behavior research pathways, Am. J. Prev. Med., 47, S144, 10.1016/j.amepre.2014.06.011 · DOI
- Berardelli, I., Serafini, G., Cortese, N., Fiaschè, F., O’Connor, R.C., and Pompili, M. (2020). The involvement of hypothalamus-pituitary-adrenal (HPA) axis in suicide risk. Brain Sci., 10. · DOI · Paper page
- Merali, 2004, Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA (A) receptor subunits in frontal cortical brain region, J. Neurosci., 24, 1478, 10.1523/JNEUROSCI.4734-03.2004 · DOI · Paper page
- Pandey, 2019, Increased protein and mRNA expression of corticotropin-releasing factor (CRF), decreased CRF receptors and CRF binding protein in specific postmortem brain areas of teenage suicide subjects, Psychoneuroendocrinology, 106, 233, 10.1016/j.psyneuen.2019.04.015 · DOI
- Gaynor, 2016, A targeted sequencing study of glutamatergic candidate genes in suicide attempters with bipolar disorder, Am. J. Med. Genet. Part B Neuropsychiatr. Genet., 171, 1080, 10.1002/ajmg.b.32479 · DOI
- Szewczyk, 2013, Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims, J. Affect. Disord., 151, 924, 10.1016/j.jad.2013.08.009 · DOI
- Kim, S., Choi, K.-H., Baykiz, A.F., and Gershenfeld, H.K. (2007). Suicide candidate genes associated with bipolar disorder and schizophrenia: An exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genom., 8. · DOI · Paper page
- Poulter, 2010, Altered organization of GABAA receptor mRNA expression in the depressed suicide brain, Front. Mol. Neurosci., 3, 3, 10.3389/neuro.02.003.2010 · DOI · Paper page
- Yin, 2020, Interactions of the GABRG2 polymorphisms and childhood trauma on suicide attempt and related traits in depressed patients, J. Affect. Disord., 266, 447, 10.1016/j.jad.2020.01.126 · DOI
- Soreni, 1999, Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts, Biol. Psychiatry, 46, 484, 10.1016/S0006-3223(98)00342-4 · DOI
- Brunner, 2001, Cholesterol, omega-3 fatty acids, and suicide risk: Empirical evidence and pathophysiological hypotheses, Fortschr. Neurol. Psychiatr., 69, 460, 10.1055/s-2001-17564 · DOI
- Kunugi, 1997, Low serum cholesterol in suicide attempters, Biol. Psychiatry, 41, 196, 10.1016/S0006-3223(95)00672-9 · DOI
- Sublette, 2020, Lipids and suicide risk, Curr. Top. Behav. Neurosci., 46, 155, 10.1007/7854_2020_163 · DOI
- Kim, 2004, Clinical application of low serum cholesterol as an indicator for suicide risk in major depression, J. Affect. Disord., 81, 161, 10.1016/S0165-0327(03)00166-6 · DOI
- Knowles, 2018, Disentangling the genetic overlap between cholesterol and suicide risk, Neuropsychopharmacology, 43, 2556, 10.1038/s41386-018-0162-1 · DOI
- Molero, 2020, Associations between statin use and suicidality, depression, anxiety, and seizures: A Swedish total-population cohort study, Lancet Psychiatry, 7, 982, 10.1016/S2215-0366(20)30311-4 · DOI
- Freemantle, 2013, Analysis of oxysterols and cholesterol in prefrontal cortex of suicides, Int. J. Neuropsychopharmacol., 16, 1241, 10.1017/S1461145712001587 · DOI · Paper page
- Kouter, 2019, Genome-wide DNA methylation patterns in suicide victims: Identification of new candidate genes, Psychiatr. Danub., 31, 392, 10.24869/psyd.2019.392 · DOI
- Squassina, 2020, MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings, Eur. Neuropsychopharmacol., 34, 39, 10.1016/j.euroneuro.2020.03.005 · DOI
- Roy, 2020, Exploiting circulating microRNAs as biomarkers in psychiatric disorders, Mol. Diagn. Ther., 24, 279, 10.1007/s40291-020-00464-9 · DOI · Paper page
- Miller, 2001, An integrative theory of prefrontal cortex function, Annu. Rev. Neurosci., 24, 167, 10.1146/annurev.neuro.24.1.167 · DOI · Paper page
- Lewis, 2020, Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation, Transl. Psychiatry, 10, 119, 10.1038/s41398-020-0792-z · DOI
- Zhu, 2020, Discriminating suicide attempters and predicting suicide risk using altered frontolimbic resting-state functional connectivity in patients with bipolar II disorder, Front. Psychiatry, 11, 597770, 10.3389/fpsyt.2020.597770 · DOI
- Guzzetta, 2007, Lithium treatment reduces suicide risk in recurrent major depressive disorder, J. Clin. Psychiatry, 68, 380, 10.4088/JCP.v68n0304 · DOI · Paper page
- King, 2018, Emerging trends in adolescent suicide prevention research, Curr. Opin. Psychol., 22, 89, 10.1016/j.copsyc.2017.08.037 · DOI
- Cwik, 2020, Suicide in the pediatric population: Screening, risk assessment and treatment, Int. Rev. Psychiatry, 32, 254, 10.1080/09540261.2019.1693351 · DOI
- Peltzman, 2020, Effects of electroconvulsive therapy on short-term suicide mortality in a risk-matched patient population, J. ECT, 36, 187, 10.1097/YCT.0000000000000665 · DOI
- Calaway, 2016, A systematic review of the safety of electroconvulsive therapy use during the first trimester of pregnancy, J. ECT, 32, 230, 10.1097/YCT.0000000000000330 · DOI
- Pompili, 2014, Electroconvulsive treatment during pregnancy: A systematic review, Expert Rev. Neurother., 14, 1377, 10.1586/14737175.2014.972373 · DOI
- Pinna, 2018, Clinical and biological predictors of response to electroconvulsive therapy (ECT): A review, Neurosci. Lett., 669, 32, 10.1016/j.neulet.2016.10.047 · DOI
- Bioque, 2019, Effects of electroconvulsive therapy in the systemic inflammatory balance of patients with severe mental disorder, Psychiatry Clin. Neurosci., 73, 628, 10.1111/pcn.12906 · DOI
- Benard, 2016, Lithium and suicide prevention in bipolar disorder, L’Encéphale, 42, 234, 10.1016/j.encep.2016.02.006 · DOI
- Smith, 2017, Lithium and suicide in mood disorders: Updated meta-review of the scientific literature, Bipolar Disord., 19, 575, 10.1111/bdi.12543 · DOI · Paper page
- Wada, 2009, Lithium and neuropsychiatric therapeutics: Neuroplasticity via. glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades, J. Pharmacol. Sci., 110, 14, 10.1254/jphs.09R02CR · DOI · Paper page
- Wilkowska, 2019, Clozapine: Promising treatment for suicidality in bipolar disorder, Psychiatr. Danub, 31, 574
- Tondo, 2018, Antisuicidal effects in mood disorders: Are they unique to lithium?, Pharmacopsychiatry, 51, 177, 10.1055/a-0596-7853 · DOI · Paper page
- Malhi, 2013, Potential mechanisms of action of lithium in bipolar disorder, CNS Drugs, 27, 135, 10.1007/s40263-013-0039-0 · DOI · Paper page
- Rapaport, 2001, The effects of lithium on ex vivo cytokine production, Biol. Psychiatry, 50, 217, 10.1016/S0006-3223(01)01144-1 · DOI
- Bosetti, 2002, Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain, Mol. Psychiatry, 7, 845, 10.1038/sj.mp.4001111 · DOI
- Griffiths, 2014, Existing and novel biological therapeutics in suicide prevention, Am. J. Prev. Med., 47, S195, 10.1016/j.amepre.2014.06.012 · DOI
- Spivak, 1998, Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine, Clin. Neuropharmacol., 21, 245
- Rassoulpour, 2006, Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain, J. Neural Transm., 113, 1355, 10.1007/s00702-005-0432-z · DOI
- Pandurangi, 2019, Inflammation, antipsychotic drugs, and evidence for effectiveness of anti-inflammatory agents in schizophrenia, Curr. Top. Behav. Neurosci., 44, 227, 10.1007/7854_2019_91 · DOI
- Duman, 2018, Ketamine and rapid-acting antidepressants: A new era in the battle against depression and suicide, F1000Research, 7, 659, 10.12688/f1000research.14344.1 · DOI · Paper page
- Ramadan, 2020, Could ketamine be the answer to treating treatment-resistant major depressive disorder?, Gen. Psychiatr., 33, e100227, 10.1136/gpsych-2020-100227 · DOI
- Veraart, 2021, Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review, J. Affect. Disord., 281, 82, 10.1016/j.jad.2020.11.123 · DOI
- Isacsson, 2014, Antidepressant drugs and the risk of suicide in children and adolescents, Pediatr. Drugs, 16, 115, 10.1007/s40272-013-0061-1 · DOI
- Teicher, 1993, Antidepressant drugs and the emergence of suicidal tendencies, Drug Saf., 8, 186, 10.2165/00002018-199308030-00002 · DOI · Paper page
- 1999, Antidepressants and suicidal risk, J. Clin. Psychiatry, 60, 94
- Patorno, 2010, Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death, JAMA, 303, 1401, 10.1001/jama.2010.410 · DOI · Paper page
- Mula, 2013, Suicide risk in people with epilepsy taking antiepileptic drugs, Bipolar Disord., 15, 622, 10.1111/bdi.12091 · DOI
- Fruhbauerova, 2019, Addiction counselors and suicide: Education and experience do not improve suicide knowledge, beliefs, or confidence in treating suicidal clients, J. Subst. Abus. Treat., 106, 29, 10.1016/j.jsat.2019.08.012 · DOI
- Lynch, 2020, Substance use disorders and risk of suicide in a general US population: A case control study, Addict. Sci. Clin. Pr., 15, 14, 10.1186/s13722-020-0181-1 · DOI · Paper page
- Zhornitsky, 2020, Interpersonal risk factors for suicide in cocaine dependence: Association with self-esteem, personality traits, and childhood abuse, Suicide Life-Threat. Behav., 50, 867, 10.1111/sltb.12621 · DOI
- Miller, 1991, Suicide risk associated with drug and alcohol dependence, J. Addict. Dis., 10, 49, 10.1300/J069v10n03_06 · DOI
- Arensman, E., Bennardi, M., Larkin, C., Wall, A., McAuliffe, C., McCarthy, J., Williamson, E., and Perry, I. (2016). Suicide among young people and adults in Ireland: Method characteristics, toxicological analysis and substance abuse histories compared. PLoS ONE, 11. · DOI
- Masferrer, L., and Caparrós, B. (2017). Risk of suicide and dysfunctional patterns of personality among bereaved substance users. Int. J. Environ. Res. Public Health, 14. · DOI
- Lasota, D., Al-Wathinani, A., Krajewski, P., Mirowska-Guzel, D., Goniewicz, K., Hertelendy, A.J., Alhazmi, R.A., Pawłowski, W., Khorram-Manesh, A., and Goniewicz, M. (2020). Alcohol and the risk of railway suicide. Int. J. Environ. Res. Public Health, 17. · DOI
- Pirkola, 2004, Suicide in alcohol-dependent individuals: Epidemiology and management, CNS Drugs., 18, 423, 10.2165/00023210-200418070-00002 · DOI
Cited by
Wiebenga, J. X. M., Heering, H. D., Eikelenboom, M., van Hemert, A. M., van Oppen, P., & Penninx, B. W. J. H. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.02.021 · Cited by 53
“Previous studies indeed found that IL-6 was more elevated in patients with more recent and violent attempts and higher suicide severity (Fernández-Sevillano et al., 2021; Sudol and Mann, 2017; Wisłowska-Stanek et al., 2021).”
ResultFatemian, H., Moslemi, H., Hosseini, Y., & Moshfeghinia, R. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.135 · Cited by 21
Milic, J., Jovic, S., & Sapic, R. (2025) · Genes · doi:10.3390/genes16050487 · Cited by 19
“An exaggerated autoimmune response to serotonin is linked to recurrent depressive episodes, while increased density of 5-HT2A receptors on platelets has been associated with suicidality and may serve as a risk marker [76,77].”
Metadata
- Authors
- Wisłowska-Stanek, A., Kołosowska, K., & Maciejak, P.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-09-23
- Volume
- 10
- Issue
- 10
- Pages
- 2519
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3202617205
- Cited by
- 110
- References
- 52
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Narodowe Centrum Nauki (2016/21/B/NZ7/02066)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.